NASDAQ
CEMI

Chembio Diagnostics Inc

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Chembio Diagnostics Inc Stock Price

Vitals

Today's Low:
$0.3570
Today's High:
$0.3899
Open Price:
$0.3600
52W Low:
$0.25
52W High:
$2.33
Prev. Close:
$0.3550
Volume:
612137

Company Statistics

Market Cap.:
$0.011 billion
Book Value:
0.659
Revenue TTM:
$0.061 billion
Operating Margin TTM:
-41.4%
Gross Profit TTM:
$0.013 billion
Gross Profit TTM:
$0.013 billion
Profit Margin:
-59.5%
Return on Assets TTM:
-29.7%
Return on Equity TTM:
-206.1%

Company Profile

Chembio Diagnostics Inc had its IPO on 2004-05-05 under the ticker symbol CEMI.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Chembio Diagnostics Inc has a staff strength of 0 employees.

Stock update

Shares of Chembio Diagnostics Inc opened at $0.36 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.36 - $0.39, and closed at $0.38.

This is a +7.04% increase from the previous day's closing price.

A total volume of 612,137 shares were traded at the close of the day’s session.

In the last one week, shares of Chembio Diagnostics Inc have increased by 0%.

Chembio Diagnostics Inc's Key Ratios

Chembio Diagnostics Inc has a market cap of $0.011 billion, indicating a price to book ratio of 0.486 and a price to sales ratio of 0.19.

In the last 12-months Chembio Diagnostics Inc’s revenue was $0.061 billion with a gross profit of $0.013 billion and an EBITDA of $-0.022 billion. The EBITDA ratio measures Chembio Diagnostics Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Chembio Diagnostics Inc’s operating margin was -41.4% while its return on assets stood at -29.7% with a return of equity of -206.1%.

In Q2, Chembio Diagnostics Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 41.8%.

Chembio Diagnostics Inc’s PE and PEG Ratio

Forward PE
6.72
Trailing PE
-
PEG
-0.48

Its diluted EPS in the last 12-months stands at $-1.426 per share while it has a forward price to earnings multiple of 6.72 and a PEG multiple of -0.48. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Chembio Diagnostics Inc’s profitability.

Chembio Diagnostics Inc stock is trading at a EV to sales ratio of 0.234 and a EV to EBITDA ratio of -0.426. Its price to sales ratio in the trailing 12-months stood at 0.19.

Chembio Diagnostics Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Chembio Diagnostics Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Chembio Diagnostics Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Chembio Diagnostics Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Chembio Diagnostics Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Chembio Diagnostics Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.38
52-Week High
$2.33
52-Week Low
$0.25
Analyst Target Price
$8

Chembio Diagnostics Inc stock is currently trading at $0.38 per share. It touched a 52-week high of $2.33 and a 52-week low of $2.33. Analysts tracking the stock have a 12-month average target price of $8.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Chembio Diagnostics Inc

The stock symbol (also called stock or share ticker) of Chembio Diagnostics Inc is CEMI

The IPO of Chembio Diagnostics Inc took place on 2004-05-05

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$8.57
-0.82
-8.73%
$2.15
-0.2
-8.51%
$98.04
-1.27
-1.28%
$4.04
-0.07
-1.66%
$2.69
0.2
+8.03%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Chembio Diagnostics, Inc. develops, manufactures, and markets point-of-care (POC) diagnostic tests that are used to detect or diagnose disease. The company is headquartered in Hauppauge, New York.

Address

3661 HORSEBLOCK ROAD, MEDFORD, NY, US